Month: August 2025

XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

Business development: Purchased mezagitamab royalty and milestone rights held by BioInvent International and will secure royalty economic interests in two early-stage partnered assets through XOMA Royalty’s recently announced acquisition of LAVA Therapeutics. Company acquisitions: Announced XOMA Royalty’s acquisitions of Turnstone Biologics, LAVA Therapeutics, and HilleVax; acted as structuring agent and provided financing for XenoTherapeutics’ acquisition of ESSA Pharma; completed the sale of Kinnate pipeline assets and distributed upfront proceeds to Kinnate contingent value right (CVR) holders. Key Pipeline advancements: Rezolute completed enrollment in Phase 3 sunRIZE study of ersodetug in patients with congenital hyperinsulinism; the Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was...

Creative Realities Reports Fiscal 2025 Second Quarter Results

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

Revenue Growth Picks Up as Year Progresses; Company on Track for Record 2025 LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal second quarter ended June 30, 2025. Highlights:Second quarter revenue of $13.0 million versus $13.1 million in the prior-year period Gross profit of $5.0 million for the three months ended June 30, 2025 versus $6.8 million in the second quarter of fiscal 2024 Adjusted EBITDA* of $1.2 million for the second quarter of 2025 versus $1.5 million in the prior-year period Annual recurring revenue (“ARR”) of approximately $18.1 million at the end of the second quarter versus $17.3 million as of March 31,...

Nayax Reports Second Quarter 2025 Results

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

Revenue of $95.6 million, recurring revenue growth of 32% Gross margin improves to 48.3% Net income of $11.7 million with Adjusted EBITDA of $12.6 million(1) Total transaction value up 34%, Customer base increases 24% Company reaffirms full year 2025 guidance HERZLIYA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX, TASE: NYAX), a global commerce payments and loyalty platform designed to help merchants scale their business, today announced its financial results for the second quarter ended June 30, 2025. “Our second quarter results reflect the successful execution of our strategic initiatives and the positive momentum of the business. We delivered yet another quarter of strong operational and financial performance driven by profitable revenue growth, robust global demand for our product solutions and services,...

FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.

Written by Customer Service on August 13, 2025. Posted in Public Companies.

WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (“FOXO” or the “Company”) announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to delist the Class A common stock of FOXO (Ticker symbol FOXO) from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A commons stock. The share price went below the NYSE minimum price of $0.10 on August 12, 2025 and was immediately suspended from trading by NYSE. The Company submitted an application to have its common stock traded on the OTC and has on August 12, 2025 received confirmation from FINRA’s Department of Market Operations that the trading symbol, “FOXO” has been assigned by them to the Common Stock...

Altus Group Responds to Media Reports

Written by Customer Service on August 13, 2025. Posted in Public Companies.

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF) issued a statement in response to recent media reports concerning a potential transaction involving the Company. While the Company has a policy not to comment on market rumours, it acknowledges a speculative recent media article. Altus Group periodically undertakes a strategic review to maximize stakeholder value. The Company is in the process of a review which includes but is not limited to acquisitions, divestitures, and a sale or merger of the Company. The Company’s board of directors is committed to acting in the best interests of the Company and its stakeholders. It is important to note that a review process may not result in any particular course of action. The Company does not intend to issue or disclose developments...

The Keg Royalties Income Fund announces Successful Closing of the Transaction with Fairfax

Written by Customer Service on August 13, 2025. Posted in Mergers And Acquisitions.

Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — The Keg Royalties Income Fund (the “Fund”) (TSX: KEG.UN) and 1543965 B.C. Ltd. (the “Purchaser”), a subsidiary of Fairfax Financial Holdings Limited (collectively with its affiliates, “Fairfax”) are pleased to announce the successful closing of the previously announced plan of arrangement (the “Transaction”) pursuant to which the Purchaser acquired all of the issued and outstanding units of the Fund (the “Units”) not otherwise owned directly or indirectly by Fairfax. In connection with the completion of the Transaction, 1543966 B.C. Ltd. is now the sole trustee of the Fund (the “Trustee”) and the Units were delisted from the Toronto Stock Exchange (“TSX”) as of the close of trading on August...

Gauzy Ltd. Announces Second Quarter 2025 Results

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated Stacks for Smart Glass New Strategic Customers Secured in Architecture, Aeronautics and Safety Tech Closed on $15 Million of Debt Financing with Mizrahi Bank, Israel’s Third Largest Bank, Including $5 Million in July Reaffirms 2025 Guidance TEL-AVIV, Israel and NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader of vision and light control technologies, today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights (Compared to Second Quarter 2024)Revenues of $20.1 million, compared to $24.4 million Gross margin of 21.4%,...

Crown Crafts Announces Financial Results for First Quarter Fiscal 2026

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

GONZALES, La., Aug. 13, 2025 (GLOBE NEWSWIRE) — Crown Crafts, Inc. (NASDAQ-CM: CRWS) (the “Company”) today reported results for the first quarter fiscal year 2026, which ended June 29, 2025. First Quarter SummaryNet sales of $15.5 million compared to $16.2 million in the prior-year quarter Gross profit of 22.7 percent compared to 24.5 percent in the first quarter of fiscal 2025 Net loss of ($1.10 million), or ($0.10) per share, compared to net loss of ($0.3 million), or ($0.03 per share), in the prior-year quarter Q1 results reflect the impact of increased tariffs Declared quarterly dividend of $0.08 per share of Series A common stockOlivia Elliott, President and Chief Executive Officer, stated, “Our first quarter results reflect the themes we outlined in our financial results for fiscal year 2025. While the Baby Boom acquisition...

Immatics Announces Second Quarter 2025 Financial Results and Business Update

Written by Customer Service on August 13, 2025. Posted in Public Companies.

Anzu-cel (anzutresgene autoleucel, IMA203) PRAME Cell Therapy: One-time infusion continues to show favorable tolerability as well as strong anti-tumor activity and durability in 33 heavily pretreated patients with metastatic melanoma in data from a Phase 1b trial presented at the 2025 ASCO Annual Meeting: 56% cORR, 12.1 months mDOR at 13.4 months mFU, 6.1 months mPFS and 15.9 months mOSAnzu-cel (IMA203) PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; interim and final analyses will occur in 2026IMA203CD8 PRAME Cell Therapy (GEN2): Phase 1a clinical trial ongoing with next data update, including dose escalation data in ovarian cancer, melanoma and synovial sarcoma, planned in 4Q 2025IMA402 PRAME Bispecific: Phase 1a clinical trial in solid tumors ongoing...

Oroco Receives Positive Resolution from Mexico’s Environment Ministry

Written by Customer Service on August 13, 2025. Posted in Public Companies.

VANCOUVER, Canada, Aug. 13, 2025 (GLOBE NEWSWIRE) — Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce that it has received a positive resolution from the Mexican Federal Secretaría del Medio Ambiente y Recursos Naturales (“SEMARNAT”) to its “informe preventivo” notice of exploration activities on the Santo Tomas Project. As a result of the positive resolution, the Company’s planned drilling and exploration activities “… do not require obtaining the authorization in matters of Environmental Impact granted by this Secretariat and therefore can be carried out in accordance with the characteristics indicated in the IP presented for the project.” Consequently, the Company may proceed with the scope of drilling and exploration on the Santo Tomas Project set out in the notice without an...

Month: August 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals